BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Pharmacyclics, Inc. 

995 East Arques Avenue

Sunnyvale  California  94086  U.S.A.
Phone: 408-774-0330 Fax: 408-774-0340


SEARCH JOBS








 Company News
Lucky Drug Made Pharmacyclics, Inc. (PCYC)' Robert Duggan A Billionaire—Can He Do It Again? 4/16/2014 8:24:34 AM    More...
Pharmacyclics, Inc. (PCYC) Files Supplemental New Drug Application For IMBRUVICA With Phase III CLL Study Data 4/8/2014 9:25:10 AM    More...
Pharmacyclics, Inc. (PCYC) Reports Fourth Quarter And Full Year 2013 Results 2/21/2014 6:18:17 AM    More...
Pharmacyclics, Inc. (PCYC) Announces Date Of Conference Call To Discuss Financial Results For Fourth Quarter And Year End 2013 2/17/2014 6:02:45 AM    More...
Pharmacyclics, Inc. (PCYC)'s Imbruvica Wins Second Cancer Approval 2/13/2014 6:58:32 AM    More...
Pharmacyclics, Inc. (PCYC) Release: Independent Data Monitoring Committee Recommends Phase III Study Of IMBRUVICA™ (Ibrutinib) Versus Ofatumumab Be Stopped Early Based On Statistically Significant Improvement In Progression Free Survival And Overall Survival 1/7/2014 10:59:54 AM    More...
Pharmacyclics, Inc. (PCYC) Announces Data Presentations For Ibrutinib In B-Cell Malignancies 12/11/2013 8:54:09 AM    More...
Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC)'s Closely Watched Leukemia Drug Effective In Long Term Study 12/9/2013 6:43:06 AM    More...
Pharmacyclics, Inc. (PCYC) Snags $50 Million As Cancer Drug Moves Toward European Approval 11/21/2013 8:06:49 AM    More...
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013 11:41:20 AM    More...
12345678910...

//-->